Last edition
News about "Covid 19 vaccine"
SK Bioscience Begins Study of Sarbecovirus Vaccine
SK bioscience has initiated a global phase I/II clinical trial of GBP511, a universal vaccine candidate targeting the Sarbecovirus family, leveraging its SKYCovione recombinant protein platform and nanoparticle technology as part of the company’s mid- to long-term strategy to advance next-generation vaccines for future pandemic preparedness.
COVID-19 Vaccine | 30/01/2026 | By News Bureau
MHRA Approves New mRNA COVID-19 Booster
The new approved vaccine, Zapomeran (Kostaive) is cleared for adults aged 18 years and above.
Covid-19 Vaccine | 05/01/2026 | By News Bureau | 165
Pfizer and BioNTech's Updated COVID-19 Vaccine Secures EMA Nod, Awaits Final EU Approval
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Pfizer- BioNTech's LP.8.1-adapted monovalent COVID-19 vaccine in the European Union.
COVID-19 Vaccine | 28/07/2025 | By Dineshwori | 182
Moderna Gets MHRA Authorization for Updated COVID-19 Vaccine
For the first time in the UK, the updated vaccine, Spikevax JN.1, will also be available to purchase privately for those who are not eligible for the NHS Autumn vaccination program.
COVID-19 Vaccine | 05/09/2024 | By Aishwarya | 387
Novavax 2024-2025 Formula COVID-19 Vaccine Gets EUA for Use in US
Pre-filled syringes of the vaccine will be available in thousands of locations, including retail and independent pharmacies and regional grocers, following the Center for Biologics Evaluation and Research release of vaccine batches.
<br />
COVID-19 Vaccine | 02/09/2024 | By Aishwarya | 742
Sanofi Signs Co-Exclusive Licensing Deal with Novavax to Co-Commercialize COVID-19 Vaccine
Sanofi has signed a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US.
COVID-19 Vaccine | 10/05/2024 | By Aishwarya | 303
BioNTech 2nd phase of Covid 19 trials completed
The vaccine, based on messenger RNA (mRNA) technology, is one of the most widely used worldwide against COVID, but has yet to receive an approval in China, which has relied only on domestically-developed vaccine
Covid 19 Vaccine | 12/05/2022 | By Sudeep Soparkar | 706
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy